ICW Healthcare Ventures

ICW Healthcare Ventures, which operates under the shorter name ICW Ventures, is a health technology venture organization based in New York, United States. Its public positioning is built around the phrase "Innovations that Change the World," and it describes itself as striving to uncover solutions that others could not find in order to deliver game-changing health technologies that improve life for everyone. Rather than functioning as a conventional venture capital fund alone, ICW presents itself as an active builder and developer of HealthTech businesses, working with a global cross-functional team on a mission to develop game-changing health solutions. The firm's visible portfolio and venture activity center on three named biotechnology companies. EdJen Biotech is described as using novel, state-of-the-art technology to design vaccines adapted for distribution in the most challenging environments. E-Star Biotech is described as utilizing innovative designer peptides to treat cardiovascular, metabolic, and kidney disease. Genomadix is also listed among the ventures, with the homepage associating it with novel, state-of-the-art technology for vaccine design adapted to challenging distribution environments. Across these ventures, ICW states that it is focused on technologies that improve outcomes and reduce the cost of care. ICW Ventures is led by a cross-functional team with both scientific and business leadership. Daniel Salva serves as President and Chairman of the Board of Directors, while Lucia Gonzalez is Chief Financial Officer. Guillaume Leroy, who holds a Pharmaceutical Science PhD, is Chief Executive Officer of EdJen Biotech and a member of the Board of Directors. Jesse Crowne, MBA MPH, is Chief Executive Officer of E-Star, and Seetha R Iyer, MS, is E-Star's Scientific Program Manager. The broader team also includes Martin A. Bell as Legal Advisor, Ana Mendez as Chief Administrative Officer, Elizabeth John, PhD, as Head of CMC, Whitney McMullin as Executive Admin Specialist, and Laura Hsu as Legal Counsel. The company is associated with New York, United States, according to its Wikidata entry, which identifies it as a company in New York. Its website domain, icw.ventures, reinforces its identity as a venture-oriented healthcare organization. ICW's stated focus on identifying and developing HealthTech breakthroughs, and on technologies that improve outcomes and reduce the cost of care, places it in the health technology and life sciences investment and development space. The firm's public materials emphasize a mission-driven, globally oriented approach to building health solutions rather than a purely financial investment strategy.

ICW Healthcare Ventures is a health technology venture organization based in New York, United States. Public information about the firm is limited, and its own website and Wikidata entry provide the primary available details. The company presents itself under the banner "Innovations that Change the World," describing a mission to uncover solutions that others could not find and to deliver game-changing health technologies that improve life for everyone. This framing positions ICW not merely as a financial investor but as an active developer of health technology ventures. The firm's visible activity centers on a portfolio of biotechnology companies. EdJen Biotech is described as using novel, state-of-the-art technology to design vaccines adapted for distribution in the most challenging environments. E-Star Biotech is described as utilizing innovative designer peptides to treat cardiovascular, metabolic, and kidney disease. Genomadix is also listed among the ventures, with the homepage associating it with novel, state-of-the-art technology for vaccine design adapted to challenging distribution environments. Across these ventures, ICW states that it is focused on technologies that improve outcomes and reduce the cost of care. ICW Ventures is led by a cross-functional team with both scientific and business leadership. Daniel Salva serves as President and Chairman of the Board of Directors, while Lucia Gonzalez is Chief Financial Officer. Guillaume Leroy, who holds a Pharmaceutical Science PhD, is Chief Executive Officer of EdJen Biotech and a member of the Board of Directors. Jesse Crowne, MBA MPH, is Chief Executive Officer of E-Star, and Seetha R Iyer, MS, is E-Star's Scientific Program Manager. The broader team also includes Martin A. Bell as Legal Advisor, Ana Mendez as Chief Administrative Officer, Elizabeth John, PhD, as Head of CMC, Whitney McMullin as Executive Admin Specialist, and Laura Hsu as Legal Counsel. The company is associated with New York, United States, according to its Wikidata entry, which identifies it as a company in New York. Its website domain, icw.ventures, reinforces its identity as a venture-oriented healthcare organization. ICW's stated focus on identifying and developing HealthTech breakthroughs, and on technologies that improve outcomes and reduce the cost of care, places it in the health technology and life sciences investment and development space. The firm's public materials emphasize a mission-driven, globally oriented approach to building health solutions rather than a purely financial investment strategy.

A mission-driven health technology venture firm focused on identifying and developing HealthTech breakthroughs that improve outcomes and reduce the cost of care.

• EdJen Biotech

  Uses novel, state-of-the-art technology to design vaccines adapted for distribution in the most challenging environments.

• E-Star Biotech

  Utilizes innovative designer peptides to treat cardiovascular, metabolic, and kidney disease.

• Genomadix

  Listed among ICW ventures; associated with novel, state-of-the-art technology for vaccine design adapted to challenging distribution environments.

1. 1ICW Venturesicw.ventures
2. 2Team — ICW Venturesicw.ventures
3. 3ICW Healthcare Ventures (United States) - Wikidatawikidata.org